TrialJournal of neuro-oncology2026
Pembrolizumab monotherapy for microsatellite instability-high or mismatch repair deficient recurrent gliomas: results from the multicohort KEYNOTE-158 study.
Capucine Baldini et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it